Search | Page 10 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Unraveling the molecular pathophysiology of myelodysplastic syndromes.

    ... define myelodysplastic syndromes (MDS): clonal hematopoiesis , aberrant differentiation, peripheral cytopenias, and risk ...

    Research Article last updated 10/11/2011 - 5:58pm.

  2. Therapeutic modalities for patients with lower-risk myelodysplastic syndromes: current options and future directions.

    ... of disease. Current therapies are aimed at promoting hematopoiesis , inhibiting apoptosis , and reducing the risk of ...

    Research Article last updated 10/11/2011 - 5:58pm.

  3. The search for better prognostic models in myelodysplastic syndromes.

    ... bone marrow disorders characterized by a failure of hematopoiesis and an increased propensity for transformation to acute ...

    Research Article last updated 10/11/2011 - 5:58pm.

  4. 5-Azacytidine in myelodysplastic syndromes: a clinical practice guideline.

    ... Myelodysplastic syndrome (MDS) is a clonal disorder of hematopoiesis that results in peripheral blood cytopenias and a marked ...

    Research Article last updated 10/11/2011 - 5:58pm.

  5. Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group.

    ... bone marrow disorders characterized by ineffective hematopoiesis , peripheral cytopenias, and a substantial risk of ...

    Research Article last updated 10/11/2011 - 5:58pm.

  6. An update on the treatment of myelodysplastic syndromes.

    ... affecting about 300,000 people worldwide. Ineffective hematopoiesis and clonal proliferation result in significant cytopenias in ...

    Research Article last updated 10/11/2011 - 5:58pm.

  7. Epigenetic therapy in myelodysplastic syndromes.

    ... - with ineffective, inadequate, and dysplastic hematopoiesis , and with an increased risk of life-threatening infections, ...

    Research Article last updated 10/11/2011 - 5:58pm.

  8. Myelodysplastic syndromes.

    ... of stem cell disorders characterized by impaired hematopoiesis resulting in low peripheral blood counts. The majority of ...

    Research Article last updated 10/11/2011 - 5:58pm.

  9. Decitabine in the treatment of myelodysplastic syndromes.

    ... stem cell disorders characterized by ineffective hematopoiesis , peripheral blood cytopenias and a propensity to transform ...

    Research Article last updated 10/11/2011 - 5:58pm.

  10. Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasirox

    ... syndromes are characterized by ineffective hematopoiesis resulting in peripheral cytopenias. The majority of patients ...

    Research Article last updated 10/11/2011 - 5:58pm.